Prenali Dwisthi Sattwika
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Prenali Dwisthi Sattwika has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Adam James Lewandowski
Nuffield Department of Population Health University of Oxford Oxford UK
7 shared publications - Paul Leeson
University of Oxford
6 shared publications - Hannah Rebecca Cutler
Division of Cardiovascular Medicine, University of Oxford, United Kingdom. (H.R.C., P.D.S., J.K., A.M.C., K.S., Y.K., A.F., S.K., A.J.L., W.L., P.L.)
5 shared publications - Winok Lapidaire
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Cardiovascular Clinical Research Facility, University of Oxford , Level 1, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford
5 shared publications Annabelle McCourt
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Cardiovascular Clinical Research Facility, University of Oxford , Level 1, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford
3 shared publications- Detty Siti Nurdiati
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
3 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 4 (3)
Cardiac morphology and flow dynamics in children born to hypertensive pregnancies
Aims: Hypertensive pregnancies affect up to 10% of pregnancies globally and are linked to greater cardiovascular risk in offspring. Subclinical cardiac changes have been reported across developmental stages. This study aimed to assess whether children born to hypertensive pregnancies exhibit altered left ventricular (LV) morphology and cardiac flow characteristics. Methods and results: In this cross-sectional study, cardiovascular magnetic resonance (CMR) was performed on a 3.0-Tesla Siemens PRISMA scanner in children aged 6–9 years: 44 offspring of hypertensive pregnancies (50% female) and 56 controls from normotensive pregnancies (37.5% female). Free-breathing real-time cine images were acquired to assess structure and function and to create a computational LV shape atlas. Four-dimensional (4D) Flow CMR was acquired to quantify LV flow component volumes and kinetic energy (KE), enabling assessment of intraventricular flow organization and energetics. Children born to hypertensive and normotensive pregnancies were matched in age (7.49 ± 0.73 and 7.41 ± 1.12 years), but those from hypertensive pregnancies had significantly shorter gestations (median 37.3 weeks [IQR 35.6–39.0] vs. 39.0 weeks [37.7–40.8], P = 0.002). Conventional cardiac measures did not differ between groups. Exploratory shape analysis identified subtle group-level LV differences, including relative prominence of the basal anterior wall, and a more convex LV outflow tract (P < 0.01; AUC = 0.654). LV retained inflow end-diastolic KE was lower in exposed offspring (3.35 [3.03–4.80] vs. 5.70 [4.35–6.80] μJ/mL; P < 0.001). Conclusion: Children born to hypertensive pregnancies show subtle group-level differences in LV morphology and diastolic flow energetics. These findings suggest early differences in cardiovascular phenotype, although their long-term clinical significance remains uncertain and requires longitudinal investigation. Registration: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT05698836. Lay Summary: This study investigated whether children born to mothers with high blood pressure during pregnancy show early differences in heart structure and blood flow.Children exposed to high blood pressure during pregnancy had subtle differences in heart shape and blood flow patterns.The differences identified were small and could only be detected using advanced heart imaging analyses. They were seen when comparing groups of children rather than being useful for identifying individual children, and their long-term importance is not yet known.
- 2 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 4 (3)
Open AccessCardiac morphology and flow dynamics in children born to hypertensive pregnancies
Aims: Hypertensive pregnancies affect up to 10% of pregnancies globally and are linked to greater cardiovascular risk in offspring. Subclinical cardiac changes have been reported across developmental stages. This study aimed to assess whether children born to hypertensive pregnancies exhibit altered left ventricular (LV) morphology and cardiac flow characteristics. Methods and results: In this cross-sectional study, cardiovascular magnetic resonance (CMR) was performed on a 3.0-Tesla Siemens PRISMA scanner in children aged 6–9 years: 44 offspring of hypertensive pregnancies (50% female) and 56 controls from normotensive pregnancies (37.5% female). Free-breathing real-time cine images were acquired to assess structure and function and to create a computational LV shape atlas. Four-dimensional (4D) Flow CMR was acquired to quantify LV flow component volumes and kinetic energy (KE), enabling assessment of intraventricular flow organization and energetics. Children born to hypertensive and normotensive pregnancies were matched in age (7.49 ± 0.73 and 7.41 ± 1.12 years), but those from hypertensive pregnancies had significantly shorter gestations (median 37.3 weeks [IQR 35.6–39.0] vs. 39.0 weeks [37.7–40.8], P = 0.002). Conventional cardiac measures did not differ between groups. Exploratory shape analysis identified subtle group-level LV differences, including relative prominence of the basal anterior wall, and a more convex LV outflow tract (P < 0.01; AUC = 0.654). LV retained inflow end-diastolic KE was lower in exposed offspring (3.35 [3.03–4.80] vs. 5.70 [4.35–6.80] μJ/mL; P < 0.001). Conclusion: Children born to hypertensive pregnancies show subtle group-level differences in LV morphology and diastolic flow energetics. These findings suggest early differences in cardiovascular phenotype, although their long-term clinical significance remains uncertain and requires longitudinal investigation. Registration: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT05698836. Lay Summary: This study investigated whether children born to mothers with high blood pressure during pregnancy show early differences in heart structure and blood flow.Children exposed to high blood pressure during pregnancy had subtle differences in heart shape and blood flow patterns.The differences identified were small and could only be detected using advanced heart imaging analyses. They were seen when comparing groups of children rather than being useful for identifying individual children, and their long-term importance is not yet known.
- Open Access
- 17 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8) , e27171
Retinal Vascular Caliber: 6 to 12 Months and 15 to 25 Years Following Hypertensive Pregnancy
BACKGROUND: Women display retinal vessel caliber abnormalities after hypertensive pregnancy, but whether these predate or reflect vascular aging is unknown. METHODS: Retinal imaging was performed in 2 cohorts: 196 women at 6 to 12 months postpartum (167 hypertensive, 29 normotensive), and 105 women at 15 to 25 years postpartum (64 hypertensive, 41 normotensive), using identical imaging/analysis protocols (Imedos Health, GmbH). Central retinal arteriolar and venular equivalents were calculated, corrected for mean arterial pressure at the time of imaging, and compared across hypertensive and normotensive pregnancy groups using multivariable linear regression models adjusted for body mass index and time postpartum. Z tests were used to compare effect sizes across time points. RESULTS: At both time points, corrected central retinal arteriolar and venular equivalents were lower after hypertensive pregnancies compared with normotensive pregnancies ( P Z =−4.19; P Z =−3.83; P P P <0.001). CONCLUSIONS: Hypertensive pregnancy is associated with retinal vessel changes up to 25 years postpartum that predate age-related reductions and are associated with early pregnancy blood pressure. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04273854 and NCT05434195.
- 17 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8) , e27171
Open AccessRetinal Vascular Caliber: 6 to 12 Months and 15 to 25 Years Following Hypertensive Pregnancy
BACKGROUND: Women display retinal vessel caliber abnormalities after hypertensive pregnancy, but whether these predate or reflect vascular aging is unknown. METHODS: Retinal imaging was performed in 2 cohorts: 196 women at 6 to 12 months postpartum (167 hypertensive, 29 normotensive), and 105 women at 15 to 25 years postpartum (64 hypertensive, 41 normotensive), using identical imaging/analysis protocols (Imedos Health, GmbH). Central retinal arteriolar and venular equivalents were calculated, corrected for mean arterial pressure at the time of imaging, and compared across hypertensive and normotensive pregnancy groups using multivariable linear regression models adjusted for body mass index and time postpartum. Z tests were used to compare effect sizes across time points. RESULTS: At both time points, corrected central retinal arteriolar and venular equivalents were lower after hypertensive pregnancies compared with normotensive pregnancies ( P Z =−4.19; P Z =−3.83; P P P <0.001). CONCLUSIONS: Hypertensive pregnancy is associated with retinal vessel changes up to 25 years postpartum that predate age-related reductions and are associated with early pregnancy blood pressure. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04273854 and NCT05434195.
- Open Access
- 15 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (4)
Applications of artificial intelligence and computational approaches to imaging for hypertension identification, phenotyping, and outcome prediction: a systematic review
Current hypertension guidelines focus on blood pressure control, but incorporating end-organ imaging could improve understanding of disease manifestations. We undertook a systematic review to evaluate current task-level applications of artificial intelligence (AI) and computational approaches to imaging for hypertension identification, phenotyping, and outcome prediction. A systematic search was conducted across multiple databases up to end of December 2025. Retrieved studies were grouped by AI task, and a thematic qualitative analysis per-task was conducted to evaluate organ-specific findings, AI methodologies, and research gaps. For quantitative synthesis, the I2 statistic derived from Cochran’s Q test was used to assess heterogeneity, and forest plots were generated to visualize effect sizes. The review was registered with PROSPERO (CRD42023427430). The search strategy yielded 48 studies. Thematic analysis categorized the studies into five major tasks, with the majority employing supervised learning for classification processes. Nearly half of the studies focused on the heart. However, paucity of studies performed multi-organ assessment, external validation, and phenotyping or predicting future risk. AI and computational approaches in imaging achieved an overall sensitivity of 0.84 [0.69–0.93] in identifying hypertension from normotension, highest with brain imaging. Sensitivity reached 0.92 [0.90–0.94] in discriminating hypertension from hypertrophic cardiomyopathy. Current research focusses primarily on hypertension prediction using single organ information. While results are promising, datasets remain small with limited external validation. There remains a need for discovery-oriented research to uncover disease heterogeneity, multi-organ phenotypes, and support personalized and targeted interventions.
- 15 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (4)
Open AccessApplications of artificial intelligence and computational approaches to imaging for hypertension identification, phenotyping, and outcome prediction: a systematic review
Current hypertension guidelines focus on blood pressure control, but incorporating end-organ imaging could improve understanding of disease manifestations. We undertook a systematic review to evaluate current task-level applications of artificial intelligence (AI) and computational approaches to imaging for hypertension identification, phenotyping, and outcome prediction. A systematic search was conducted across multiple databases up to end of December 2025. Retrieved studies were grouped by AI task, and a thematic qualitative analysis per-task was conducted to evaluate organ-specific findings, AI methodologies, and research gaps. For quantitative synthesis, the I2 statistic derived from Cochran’s Q test was used to assess heterogeneity, and forest plots were generated to visualize effect sizes. The review was registered with PROSPERO (CRD42023427430). The search strategy yielded 48 studies. Thematic analysis categorized the studies into five major tasks, with the majority employing supervised learning for classification processes. Nearly half of the studies focused on the heart. However, paucity of studies performed multi-organ assessment, external validation, and phenotyping or predicting future risk. AI and computational approaches in imaging achieved an overall sensitivity of 0.84 [0.69–0.93] in identifying hypertension from normotension, highest with brain imaging. Sensitivity reached 0.92 [0.90–0.94] in discriminating hypertension from hypertrophic cardiomyopathy. Current research focusses primarily on hypertension prediction using single organ information. While results are promising, datasets remain small with limited external validation. There remains a need for discovery-oriented research to uncover disease heterogeneity, multi-organ phenotypes, and support personalized and targeted interventions.
- Open Access
- 6 November 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Pregnancy Outcomes in Adult Congenital Heart Disease Patients with Pulmonary Hypertension in Indonesia
Congenital heart disease (CHD) and pulmonary hypertension represent significant risk factors for adverse pregnancy outcomes and are associated with considerable maternal mortality, contributing to approximately 9% of maternal deaths globally. Among cardiovascular diseases complicating pregnancy, CHD is the most prevalent subtype. Here we conducted a comprehensive literature review on maternal and foetal outcomes associated with adult CHD-related pulmonary hypertension, also incorporating data from four pulmonary hypertension centres in Indonesia. Consistent with global epidemiological trends, atrial septal defect emerged as the most frequently observed form of CHD, followed by ventricular septal defect, across the four Indonesian centres. Maternal cardiovascular complications in this context include heart failure, arrhythmias, pulmonary hypertensive crises, thromboembolic events and aortic dissection. These haemodynamic disturbances further elevate the risk of adverse foetal outcomes, such as prematurity, low birth weight, intrauterine growth restriction and foetal demise. Effective and timely management of CHD and pulmonary hypertension – centred on optimising right ventricular function during pregnancy – is critical. Implementation of a comprehensive, multidisciplinary care approach, alongside the expansion of screening programmes for CHD in pregnant populations, is essential to improve maternal and foetal outcomes.
- 6 November 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Open AccessPregnancy Outcomes in Adult Congenital Heart Disease Patients with Pulmonary Hypertension in Indonesia
Congenital heart disease (CHD) and pulmonary hypertension represent significant risk factors for adverse pregnancy outcomes and are associated with considerable maternal mortality, contributing to approximately 9% of maternal deaths globally. Among cardiovascular diseases complicating pregnancy, CHD is the most prevalent subtype. Here we conducted a comprehensive literature review on maternal and foetal outcomes associated with adult CHD-related pulmonary hypertension, also incorporating data from four pulmonary hypertension centres in Indonesia. Consistent with global epidemiological trends, atrial septal defect emerged as the most frequently observed form of CHD, followed by ventricular septal defect, across the four Indonesian centres. Maternal cardiovascular complications in this context include heart failure, arrhythmias, pulmonary hypertensive crises, thromboembolic events and aortic dissection. These haemodynamic disturbances further elevate the risk of adverse foetal outcomes, such as prematurity, low birth weight, intrauterine growth restriction and foetal demise. Effective and timely management of CHD and pulmonary hypertension – centred on optimising right ventricular function during pregnancy – is critical. Implementation of a comprehensive, multidisciplinary care approach, alongside the expansion of screening programmes for CHD in pregnant populations, is essential to improve maternal and foetal outcomes.
- Open Access
- 1 November 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (11) , 1948-1958
Subclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders
BACKGROUND: Hypertensive pregnancies are associated with increased risks of renal failure in pregnancy and later life. However, traditional markers of renal function normalize postpartum, making identification of those at future disease risk difficult. We studied whether the type and severity of hypertensive pregnancy associated with postpartum renal structure. METHODS: One hundred and twenty-five women from interventional trials (61 preeclamptic, 33 gestational hypertension, and 31 normotensive pregnancy), aged ≥18 years, were imaged using magnetic resonance imaging 6 to 12 months postpartum. Anthropometric, demographic, blood pressure, and blood sample data were collected during pregnancy and postpartum. Kidney volume indexed to body surface area and corticomedullary differentiation were compared between groups using a 1-way ANCOVA, whereas associations with other outcomes were assessed using correlation tests. RESULTS: Postpartum total kidney volume indexed to body surface area was smaller in women who had preeclampsia compared with those who had gestational hypertension or a normotensive pregnancy ( P =0.049). Total kidney volume postpartum correlated with estimated glomerular filtration rate at delivery ( P P =0.02) and normotensive women ( P =0.007). There were no associations between renal measures and blood pressure during or after pregnancy. CONCLUSIONS: At 6 to 12 months postpartum, preeclamptic women have smaller kidney volumes than women with gestational hypertension or normotensive pregnancies. These smaller volumes relate to lower renal function at delivery but not corticomedullary differentiation, which only differed in women with gestational hypertension. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT04273854 and NCT05434195.
- 1 November 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (11) , 1948-1958
Open AccessSubclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders
BACKGROUND: Hypertensive pregnancies are associated with increased risks of renal failure in pregnancy and later life. However, traditional markers of renal function normalize postpartum, making identification of those at future disease risk difficult. We studied whether the type and severity of hypertensive pregnancy associated with postpartum renal structure. METHODS: One hundred and twenty-five women from interventional trials (61 preeclamptic, 33 gestational hypertension, and 31 normotensive pregnancy), aged ≥18 years, were imaged using magnetic resonance imaging 6 to 12 months postpartum. Anthropometric, demographic, blood pressure, and blood sample data were collected during pregnancy and postpartum. Kidney volume indexed to body surface area and corticomedullary differentiation were compared between groups using a 1-way ANCOVA, whereas associations with other outcomes were assessed using correlation tests. RESULTS: Postpartum total kidney volume indexed to body surface area was smaller in women who had preeclampsia compared with those who had gestational hypertension or a normotensive pregnancy ( P =0.049). Total kidney volume postpartum correlated with estimated glomerular filtration rate at delivery ( P P =0.02) and normotensive women ( P =0.007). There were no associations between renal measures and blood pressure during or after pregnancy. CONCLUSIONS: At 6 to 12 months postpartum, preeclamptic women have smaller kidney volumes than women with gestational hypertension or normotensive pregnancies. These smaller volumes relate to lower renal function at delivery but not corticomedullary differentiation, which only differed in women with gestational hypertension. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT04273854 and NCT05434195.
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e033617
Multi‐Organ Phenotypes of Offspring Born Following Hypertensive Disorders of Pregnancy: A Systematic Review
Background: Hypertensive pregnancies are associated with an increased risk of cardiovascular and neurological diseases in the offspring during later life. However, less is known about the potential impact on multi‐organ phenotypes in offspring before disease symptoms occur. The objective of this systematic review was to determine the associations of fetal exposure to maternal hypertensive pregnancy with multi‐organ phenotypes across developmental stages. Methods and Results: Ovid MEDLINE, EMBASE, CENTRAL (Cochrane Central Register of Controlled Trials), WoS, Scopus, CINAHL, and ClinicalTrials.gov were systematically searched until February 2024. Records were independently screened by 2 authors. Studies reporting on the structure or function of the heart, blood vessels, brain, liver, and kidneys in offspring of hypertensive pregnancies compared with a normotensive control population were included. Risk of bias was assessed using the Newcastle‐Ottawa Scale. Extracted data were presented using harvest plots. Seventy‐three studies including 7091 offspring of hypertensive pregnancies and 42 164 controls were identified that met the inclusion criteria. Thirty‐two studies were investigations in fetuses, 24 in neonates and infants, 12 in children, 2 in adolescents, and 3 in adults. Offspring of hypertensive pregnancies had structural and functional changes in the heart compared with controls in some studies across developmental stages. Offspring of hypertensive pregnancies also had smaller occipital and parietal vessels, higher aortic intima‐media thickness, and lower retinal arteriolar‐to‐venular ratio. Some conflicting evidence existed for other phenotypical alterations. Conclusions: There is still inconsistent evidence of multi‐organ structural and functional differences in offspring of hypertensive pregnancies. The evidence base could therefore be further strengthened through well‐designed and conducted prospective studies. Registration Information: www.crd.york.ac.uk . Unique Identifier: CRD42023387550.
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e033617
Open AccessMulti‐Organ Phenotypes of Offspring Born Following Hypertensive Disorders of Pregnancy: A Systematic Review
Background: Hypertensive pregnancies are associated with an increased risk of cardiovascular and neurological diseases in the offspring during later life. However, less is known about the potential impact on multi‐organ phenotypes in offspring before disease symptoms occur. The objective of this systematic review was to determine the associations of fetal exposure to maternal hypertensive pregnancy with multi‐organ phenotypes across developmental stages. Methods and Results: Ovid MEDLINE, EMBASE, CENTRAL (Cochrane Central Register of Controlled Trials), WoS, Scopus, CINAHL, and ClinicalTrials.gov were systematically searched until February 2024. Records were independently screened by 2 authors. Studies reporting on the structure or function of the heart, blood vessels, brain, liver, and kidneys in offspring of hypertensive pregnancies compared with a normotensive control population were included. Risk of bias was assessed using the Newcastle‐Ottawa Scale. Extracted data were presented using harvest plots. Seventy‐three studies including 7091 offspring of hypertensive pregnancies and 42 164 controls were identified that met the inclusion criteria. Thirty‐two studies were investigations in fetuses, 24 in neonates and infants, 12 in children, 2 in adolescents, and 3 in adults. Offspring of hypertensive pregnancies had structural and functional changes in the heart compared with controls in some studies across developmental stages. Offspring of hypertensive pregnancies also had smaller occipital and parietal vessels, higher aortic intima‐media thickness, and lower retinal arteriolar‐to‐venular ratio. Some conflicting evidence existed for other phenotypical alterations. Conclusions: There is still inconsistent evidence of multi‐organ structural and functional differences in offspring of hypertensive pregnancies. The evidence base could therefore be further strengthened through well‐designed and conducted prospective studies. Registration Information: www.crd.york.ac.uk . Unique Identifier: CRD42023387550.
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 848-850
Holistic MRI Acquisition in Preeclamptic Pregnancies: A New Avenue for Clinical Investigations?
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 848-850
Holistic MRI Acquisition in Preeclamptic Pregnancies: A New Avenue for Clinical Investigations?
- Open Access
- 22 August 2023
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 31 (1) , 77-99
Temporal patterns of pre- and post-natal target organ damage associated with hypertensive pregnancy: a systematic review
Aims: Hypertensive pregnancy is associated with increased risks of developing a range of vascular disorders in later life. Understanding when hypertensive target organ damage first emerges could guide optimal timing of preventive interventions. This review identifies evidence of hypertensive target organ damage across cardiac, vascular, cerebral, and renal systems at different time points from pregnancy to postpartum. Methods and results: Systematic review of Ovid/MEDLINE, EMBASE, and ClinicalTrials.gov up to and including February 2023 including review of reference lists. Identified articles underwent evaluation via a synthesis without meta-analysis using a vote-counting approach based on direction of effect, regardless of statistical significance. Risk of bias was assessed for each outcome domain, and only higher quality studies were used for final analysis. From 7644 articles, 76 studies, including data from 1 742 698 pregnancies, were identified of high quality that reported either blood pressure trajectories or target organ damage during or after a hypertensive pregnancy. Left ventricular hypertrophy, white matter lesions, proteinuria, and retinal microvasculature changes were first evident in women during a hypertensive pregnancy. Cardiac, cerebral, and retinal changes were also reported in studies performed during the early and late post-partum period despite reduction in blood pressure early postpartum. Cognitive dysfunction was first reported late postpartum. Conclusion: The majority of target organ damage reported during a hypertensive pregnancy remains evident throughout the early and late post-partum period despite variation in blood pressure. Early peri-partum strategies may be required to prevent or reverse target organ damage in women who have had a hypertensive pregnancy.
- 22 August 2023
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 31 (1) , 77-99
Open AccessTemporal patterns of pre- and post-natal target organ damage associated with hypertensive pregnancy: a systematic review
Aims: Hypertensive pregnancy is associated with increased risks of developing a range of vascular disorders in later life. Understanding when hypertensive target organ damage first emerges could guide optimal timing of preventive interventions. This review identifies evidence of hypertensive target organ damage across cardiac, vascular, cerebral, and renal systems at different time points from pregnancy to postpartum. Methods and results: Systematic review of Ovid/MEDLINE, EMBASE, and ClinicalTrials.gov up to and including February 2023 including review of reference lists. Identified articles underwent evaluation via a synthesis without meta-analysis using a vote-counting approach based on direction of effect, regardless of statistical significance. Risk of bias was assessed for each outcome domain, and only higher quality studies were used for final analysis. From 7644 articles, 76 studies, including data from 1 742 698 pregnancies, were identified of high quality that reported either blood pressure trajectories or target organ damage during or after a hypertensive pregnancy. Left ventricular hypertrophy, white matter lesions, proteinuria, and retinal microvasculature changes were first evident in women during a hypertensive pregnancy. Cardiac, cerebral, and retinal changes were also reported in studies performed during the early and late post-partum period despite reduction in blood pressure early postpartum. Cognitive dysfunction was first reported late postpartum. Conclusion: The majority of target organ damage reported during a hypertensive pregnancy remains evident throughout the early and late post-partum period despite variation in blood pressure. Early peri-partum strategies may be required to prevent or reverse target organ damage in women who have had a hypertensive pregnancy.
- 11 January 2023
- Published by Taylor & Francis in Infectious Diseases
- Vol. 55 (3) , 221-233
Anti-cytomegalovirus preemptive therapy to prevent cytomegalovirus disease in HIV-infected patients: a systematic review
HIV patients are at higher risk of contracting and developing into an asymptomatic form of CMV infection. This review aimed to evaluate the efficacy and safety of preemptive therapy for preventing CMV disease in HIV patients. The electronic search was conducted in MEDLINE/PubMed and CENTRAL from inception until 9 September 2022. Studies were included if they assessed the efficacy or safety of anti-CMV preemptive therapy compared to placebo or no therapy. Risk of bias were assessed using the Cochrane Risk of Bias tool for randomized trials version 2 or the Cochrane Collaboration Risk of Bias in Non-randomized Studies of Interventions. The random-effects model was used to calculate effect sizes. We identified six RCTs (2135 participants) and four observational studies (395 participants), with five RCTs were performed before highly active antiretroviral therapy (HAART) era. Preemptive therapy did not reduce the incidence of CMV disease (RR 0.84, 95% CI: 0.59–1.18), yet reduced the RR of all-cause mortality rate by 26% (RR 0.85, 95% CI: 0.74–0.97) with a low quality of evidence. The incidence of neutropenia as an adverse event increased significantly (RR 2.47, 95% CI: 1.12–5.45) with moderate quality of evidence. With the advent of HAART, a limited number of studies have been performed to explore anti-CMV preemptive therapy due to the improved outcomes of HIV patients with CMV viremia. Therefore, optimal HAART should take precedence over anti-CMV preemptive therapy. The protocol for this review was registered in the Prospective Register of Systematic Reviews (CRD42020145765).
- 11 January 2023
- Published by Taylor & Francis in Infectious Diseases
- Vol. 55 (3) , 221-233
Anti-cytomegalovirus preemptive therapy to prevent cytomegalovirus disease in HIV-infected patients: a systematic review
HIV patients are at higher risk of contracting and developing into an asymptomatic form of CMV infection. This review aimed to evaluate the efficacy and safety of preemptive therapy for preventing CMV disease in HIV patients. The electronic search was conducted in MEDLINE/PubMed and CENTRAL from inception until 9 September 2022. Studies were included if they assessed the efficacy or safety of anti-CMV preemptive therapy compared to placebo or no therapy. Risk of bias were assessed using the Cochrane Risk of Bias tool for randomized trials version 2 or the Cochrane Collaboration Risk of Bias in Non-randomized Studies of Interventions. The random-effects model was used to calculate effect sizes. We identified six RCTs (2135 participants) and four observational studies (395 participants), with five RCTs were performed before highly active antiretroviral therapy (HAART) era. Preemptive therapy did not reduce the incidence of CMV disease (RR 0.84, 95% CI: 0.59–1.18), yet reduced the RR of all-cause mortality rate by 26% (RR 0.85, 95% CI: 0.74–0.97) with a low quality of evidence. The incidence of neutropenia as an adverse event increased significantly (RR 2.47, 95% CI: 1.12–5.45) with moderate quality of evidence. With the advent of HAART, a limited number of studies have been performed to explore anti-CMV preemptive therapy due to the improved outcomes of HIV patients with CMV viremia. Therefore, optimal HAART should take precedence over anti-CMV preemptive therapy. The protocol for this review was registered in the Prospective Register of Systematic Reviews (CRD42020145765).
- 24 September 2019
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 42 (11) , 607-611
Impressive Response to Capecitabine in a Patient with Obstructive Jaundice due to Metastatic Triple-Negative Breast Cancer
Background: Metastatic breast cancer with obstructive jaundice due to para-aortic lymph node enlargement is an unusual case that poses a therapeutic challenge in determining a chemotherapy regimen. Case Report: A 61-year-old woman presented with triple-negative left invasive ductal breast carcinoma with liver and pulmonary metastases. After receiving gemcitabine and carboplatin as the 4th-line treatment, chemotherapy was postponed due to an increased bilirubin level. Abdominal imaging revealed para-aortic lymph node metastases compressing the distal common hepatic duct. The patient then received capecitabine along with ursodeoxycholic acid. This relieved her jaundice after 8 cycles of chemotherapy, and radiologic evaluation revealed a complete resolution of the obstructive jaundice. Conclusion: This finding emphasizes the success of capecitabine regimen as a salvage therapy in a metastatic breast cancer patient with hyperbilirubinemia and opens up the possibility of optimizing systemic chemotherapy for metastatic obstructive jaundice in the setting of limited facility resources.
- 24 September 2019
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 42 (11) , 607-611
Impressive Response to Capecitabine in a Patient with Obstructive Jaundice due to Metastatic Triple-Negative Breast Cancer
Background: Metastatic breast cancer with obstructive jaundice due to para-aortic lymph node enlargement is an unusual case that poses a therapeutic challenge in determining a chemotherapy regimen. Case Report: A 61-year-old woman presented with triple-negative left invasive ductal breast carcinoma with liver and pulmonary metastases. After receiving gemcitabine and carboplatin as the 4th-line treatment, chemotherapy was postponed due to an increased bilirubin level. Abdominal imaging revealed para-aortic lymph node metastases compressing the distal common hepatic duct. The patient then received capecitabine along with ursodeoxycholic acid. This relieved her jaundice after 8 cycles of chemotherapy, and radiologic evaluation revealed a complete resolution of the obstructive jaundice. Conclusion: This finding emphasizes the success of capecitabine regimen as a salvage therapy in a metastatic breast cancer patient with hyperbilirubinemia and opens up the possibility of optimizing systemic chemotherapy for metastatic obstructive jaundice in the setting of limited facility resources.